C-Peptide Levels Correlate to Pre-Diabetes Risk Among Women with a History of Gestational Diabetes
Gestational diabetes mellitus (GDM) is impaired glucose tolerance in some pregnant women and has been steadily increasing woldwide.1 In addition, GDM affects nearly one in seven pregnancies and leads to a three to seven-fold increase in risk of developing type II diabetes later in life.2 Recently, a team of researchers, led by Ping Yin of the Shanghai Ninth People’s Hospital and Ping Shao of Tianjin Women’s and Children’s Health Center, published findings about a link between the risk of pre-diabetes and diabetes and serum C-Peptide levels in Chinese women who have a history of gestational diabetes. They found a correlation by looking at a cross-sectional study of 1263 Chinese women and using statistical analysis to analyze C-Peptide serum levels. Interestingly, this is independent of body mass index (BMI) and fasting insulin levels, although both BMI and C-Peptide levels are risk factors.3 Future research into C-Peptide levels and its connection to diabetes are certainly warranted.
- P. Yin et al., Journal of Diabetes and Its Complications, 0(0), 2017. [Article in print] Retrieved from http://www.jdcjournal.com/article/S1056-8727(17)30953-4/fulltext